Skip Navigation

This Article
Right arrow Abstract
Right arrow FREE Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrowRequest Permissions
Right arrow Disclaimer

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
Rheumatology Daoussis et al. 10.1093/rheumatology/kep093

Supplementary Data

files

Files in this Data Supplement:



This Article
Right arrow Abstract
Right arrow FREE Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrowRequest Permissions
Right arrow Disclaimer